Phalanx Biotech collaborated with clinicians and genetic medicine experts in the design and development of pediatric chromosomal microarray to detect DNA microamplification and microdeletions within the full genome. This one microarray provides screening for 500+ hereditary disorders arising from CNVs, and features excellent discriminative power and sensitivity.

Specifically designed for Asian genes, it is developed to screen for developmental delay, intellectual disorder, as well as 82 small CNVs and nearly 100 large CNVs and aneuploidy disorders.

By combining the advantages of “Chromosomal Microarray Analysis for DD/ID (Cyto-390)” and “Whole Exome Sequencing (WES) for DD/ID”, it is possible to conduct efficient investigation on the cause of disorders including CNVs and SNVs. The result of analysis supports the physician in determining the condition and providing the best management.